Plasma Levels of S100A8/A9 and Neopterin in COVID-19 Patient Clusters

Additional file 9 contains plasma biomarker measurements for severe COVID-19 patients. The dataset, authored by Ronaldo Lira-Junior and last updated on 2026-05-30, is a 10.3 KB XLSX file. It likely contains quantitative levels of S100A8/A9 and neopterin across interferon-stimulated gene-defined patient clusters.

Use Cases

• Correlate S100A8/A9 levels with interferon response heterogeneity mentioned in the title
• Analyze neopterin as a marker of immune activation in severe COVID-19
• Validate interferon-stimulated gene-defined patient clusters using plasma biomarker data

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• Focuses on specific plasma biomarkers (S100A8/A9 and neopterin) relevant to severe COVID-19.

Limitations

• Dataset is very small at 10.3 KB, indicating limited scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Freshness

Last updated 2026-05-30 03:35:29